Caspase-1 regulates the inflammatory process leading to autoimmune demyelination

Roberto Furlan, Gianvito Martino, Francesca Galbiati, Pietro L. Poliani, Simona Smiroldo, Alessendra Bergami, Gaetano Desina, Giancarlo Comi, Richard Flavell, Michael S. Su, Luciano Adorini

Research output: Contribution to journalArticle

157 Citations (Scopus)

Abstract

T cell-mediated inflammation is considered to play a key role in the pathogenic mechanisms sustaining multiple sclerosis (MS). Caspase-1, formerly designated IL-1β-converting enzyme, is crucially involved in immune-mediated inflammation because of its pivotal role in regulating the cellular export of IL-1β and IL-18. We studied the role of caspase-1 in experimental autoimmune encephalomyelitis (EAE), the animal model for MS. Caspase-1 is transcriptionally induced during EAE, and its levels correlate with the clinical course and transcription rate of proinflammatory cytokines such as TNF-α, IL-1β, IFN-γ and IL-6. A reduction of EAE incidence and severity is observed in caspase-1-deficient mice, depending on the immunogenicity and on the amount of the encephalitogenic myelin oligodendrocyte glycoprotein (MOG) peptide used. In caspase-1-deficient mice, reduced EAE incidence correlates with defective development of anti-MOG IFN-γ-producing Th1 cells. Finally, pharmacological blockade of caspase-1 in Biozzi AB/H mice, immunized with spinal cord homogenate or MOG35-55 peptide, by the caspase-1-inhibitor Z-Val-Ala-DL-Asp-fluoromethylketone, significantly reduces EAE incidence in a preventive but not in a therapeutic protocol. These results indicate that caspase-1 plays an important role in the early stage of the immune-mediated inflammatory process leading to EAE, thus representing a possible therapeutic target in the acute phase of relapsing remitting MS.

Original languageEnglish
Pages (from-to)2403-2409
Number of pages7
JournalJournal of Immunology
Volume163
Issue number5
Publication statusPublished - Sep 1 1999

Fingerprint

Caspase 1
Demyelinating Diseases
Autoimmune Experimental Encephalomyelitis
Interleukin-1
Myelin-Oligodendrocyte Glycoprotein
Multiple Sclerosis
Incidence
Inflammation
Relapsing-Remitting Multiple Sclerosis
Peptides
Th1 Cells
Interleukin-18
Interleukin-6
Spinal Cord
Animal Models
Pharmacology
Cytokines
T-Lymphocytes
Enzymes
Therapeutics

ASJC Scopus subject areas

  • Immunology

Cite this

Furlan, R., Martino, G., Galbiati, F., Poliani, P. L., Smiroldo, S., Bergami, A., ... Adorini, L. (1999). Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. Journal of Immunology, 163(5), 2403-2409.

Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. / Furlan, Roberto; Martino, Gianvito; Galbiati, Francesca; Poliani, Pietro L.; Smiroldo, Simona; Bergami, Alessendra; Desina, Gaetano; Comi, Giancarlo; Flavell, Richard; Su, Michael S.; Adorini, Luciano.

In: Journal of Immunology, Vol. 163, No. 5, 01.09.1999, p. 2403-2409.

Research output: Contribution to journalArticle

Furlan, R, Martino, G, Galbiati, F, Poliani, PL, Smiroldo, S, Bergami, A, Desina, G, Comi, G, Flavell, R, Su, MS & Adorini, L 1999, 'Caspase-1 regulates the inflammatory process leading to autoimmune demyelination', Journal of Immunology, vol. 163, no. 5, pp. 2403-2409.
Furlan R, Martino G, Galbiati F, Poliani PL, Smiroldo S, Bergami A et al. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. Journal of Immunology. 1999 Sep 1;163(5):2403-2409.
Furlan, Roberto ; Martino, Gianvito ; Galbiati, Francesca ; Poliani, Pietro L. ; Smiroldo, Simona ; Bergami, Alessendra ; Desina, Gaetano ; Comi, Giancarlo ; Flavell, Richard ; Su, Michael S. ; Adorini, Luciano. / Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. In: Journal of Immunology. 1999 ; Vol. 163, No. 5. pp. 2403-2409.
@article{b0e04344e5a2494cb2d2bdecdd3620e9,
title = "Caspase-1 regulates the inflammatory process leading to autoimmune demyelination",
abstract = "T cell-mediated inflammation is considered to play a key role in the pathogenic mechanisms sustaining multiple sclerosis (MS). Caspase-1, formerly designated IL-1β-converting enzyme, is crucially involved in immune-mediated inflammation because of its pivotal role in regulating the cellular export of IL-1β and IL-18. We studied the role of caspase-1 in experimental autoimmune encephalomyelitis (EAE), the animal model for MS. Caspase-1 is transcriptionally induced during EAE, and its levels correlate with the clinical course and transcription rate of proinflammatory cytokines such as TNF-α, IL-1β, IFN-γ and IL-6. A reduction of EAE incidence and severity is observed in caspase-1-deficient mice, depending on the immunogenicity and on the amount of the encephalitogenic myelin oligodendrocyte glycoprotein (MOG) peptide used. In caspase-1-deficient mice, reduced EAE incidence correlates with defective development of anti-MOG IFN-γ-producing Th1 cells. Finally, pharmacological blockade of caspase-1 in Biozzi AB/H mice, immunized with spinal cord homogenate or MOG35-55 peptide, by the caspase-1-inhibitor Z-Val-Ala-DL-Asp-fluoromethylketone, significantly reduces EAE incidence in a preventive but not in a therapeutic protocol. These results indicate that caspase-1 plays an important role in the early stage of the immune-mediated inflammatory process leading to EAE, thus representing a possible therapeutic target in the acute phase of relapsing remitting MS.",
author = "Roberto Furlan and Gianvito Martino and Francesca Galbiati and Poliani, {Pietro L.} and Simona Smiroldo and Alessendra Bergami and Gaetano Desina and Giancarlo Comi and Richard Flavell and Su, {Michael S.} and Luciano Adorini",
year = "1999",
month = "9",
day = "1",
language = "English",
volume = "163",
pages = "2403--2409",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "5",

}

TY - JOUR

T1 - Caspase-1 regulates the inflammatory process leading to autoimmune demyelination

AU - Furlan, Roberto

AU - Martino, Gianvito

AU - Galbiati, Francesca

AU - Poliani, Pietro L.

AU - Smiroldo, Simona

AU - Bergami, Alessendra

AU - Desina, Gaetano

AU - Comi, Giancarlo

AU - Flavell, Richard

AU - Su, Michael S.

AU - Adorini, Luciano

PY - 1999/9/1

Y1 - 1999/9/1

N2 - T cell-mediated inflammation is considered to play a key role in the pathogenic mechanisms sustaining multiple sclerosis (MS). Caspase-1, formerly designated IL-1β-converting enzyme, is crucially involved in immune-mediated inflammation because of its pivotal role in regulating the cellular export of IL-1β and IL-18. We studied the role of caspase-1 in experimental autoimmune encephalomyelitis (EAE), the animal model for MS. Caspase-1 is transcriptionally induced during EAE, and its levels correlate with the clinical course and transcription rate of proinflammatory cytokines such as TNF-α, IL-1β, IFN-γ and IL-6. A reduction of EAE incidence and severity is observed in caspase-1-deficient mice, depending on the immunogenicity and on the amount of the encephalitogenic myelin oligodendrocyte glycoprotein (MOG) peptide used. In caspase-1-deficient mice, reduced EAE incidence correlates with defective development of anti-MOG IFN-γ-producing Th1 cells. Finally, pharmacological blockade of caspase-1 in Biozzi AB/H mice, immunized with spinal cord homogenate or MOG35-55 peptide, by the caspase-1-inhibitor Z-Val-Ala-DL-Asp-fluoromethylketone, significantly reduces EAE incidence in a preventive but not in a therapeutic protocol. These results indicate that caspase-1 plays an important role in the early stage of the immune-mediated inflammatory process leading to EAE, thus representing a possible therapeutic target in the acute phase of relapsing remitting MS.

AB - T cell-mediated inflammation is considered to play a key role in the pathogenic mechanisms sustaining multiple sclerosis (MS). Caspase-1, formerly designated IL-1β-converting enzyme, is crucially involved in immune-mediated inflammation because of its pivotal role in regulating the cellular export of IL-1β and IL-18. We studied the role of caspase-1 in experimental autoimmune encephalomyelitis (EAE), the animal model for MS. Caspase-1 is transcriptionally induced during EAE, and its levels correlate with the clinical course and transcription rate of proinflammatory cytokines such as TNF-α, IL-1β, IFN-γ and IL-6. A reduction of EAE incidence and severity is observed in caspase-1-deficient mice, depending on the immunogenicity and on the amount of the encephalitogenic myelin oligodendrocyte glycoprotein (MOG) peptide used. In caspase-1-deficient mice, reduced EAE incidence correlates with defective development of anti-MOG IFN-γ-producing Th1 cells. Finally, pharmacological blockade of caspase-1 in Biozzi AB/H mice, immunized with spinal cord homogenate or MOG35-55 peptide, by the caspase-1-inhibitor Z-Val-Ala-DL-Asp-fluoromethylketone, significantly reduces EAE incidence in a preventive but not in a therapeutic protocol. These results indicate that caspase-1 plays an important role in the early stage of the immune-mediated inflammatory process leading to EAE, thus representing a possible therapeutic target in the acute phase of relapsing remitting MS.

UR - http://www.scopus.com/inward/record.url?scp=0033198269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033198269&partnerID=8YFLogxK

M3 - Article

C2 - 10452974

AN - SCOPUS:0033198269

VL - 163

SP - 2403

EP - 2409

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 5

ER -